tetano
Editor, Senior Moderator
Eur J Clin Invest. 2020 Apr 15:e13233. doi: 10.1111/eci.13233. [Epub ahead of print]
Concerns related to COVID-19 pandemic among patients with Inflammatory Bowel Disease, and its influence on patients management.
Bodini G[SUP]1[/SUP], Demarzo MG[SUP]1[/SUP], Casagrande E[SUP]1[/SUP], De Maria C[SUP]1[/SUP], Kayali S[SUP]1[/SUP], Ziola S[SUP]1[/SUP], Giannini EG[SUP]1[/SUP].
Author information
Abstract
A novel coronavirus, currently identified as COVID-19, was recently defined as the cause of a cluster of patients with pneumonia of unknown origin that was initially reported from Wuhan, Hubei province, People's Republic of China.
This article is protected by copyright. All rights reserved.
PMID:32294238DOI:10.1111/eci.13233
Concerns related to COVID-19 pandemic among patients with Inflammatory Bowel Disease, and its influence on patients management.
Bodini G[SUP]1[/SUP], Demarzo MG[SUP]1[/SUP], Casagrande E[SUP]1[/SUP], De Maria C[SUP]1[/SUP], Kayali S[SUP]1[/SUP], Ziola S[SUP]1[/SUP], Giannini EG[SUP]1[/SUP].
Author information
Abstract
A novel coronavirus, currently identified as COVID-19, was recently defined as the cause of a cluster of patients with pneumonia of unknown origin that was initially reported from Wuhan, Hubei province, People's Republic of China.
This article is protected by copyright. All rights reserved.
PMID:32294238DOI:10.1111/eci.13233